Vaping after quitting smoking is linked to lung cancer
A study of 4.5 million people suggests that ex-smokers who take up vaping are more at risk of dying from lung cancer than people who quit without the use of e-cigarettes
A study of 4.5 million people suggests that ex-smokers who take up vaping are more at risk of dying from lung cancer than people who quit without the
Read Full Story at New Scientist →Why This Matters
For decades, e-cigarettes were marketed as a safer alternative for smokers looking to quit, but emerging data suggests this transition may not be risk-free. The study’s findings challenge a fundamental assumption in public health—that replacing tobacco with vaping eliminates cancer risks entirely. As millions of ex-smokers now vape, the long-term consequences of this choice demand urgent scrutiny, particularly for those who believed they were making a healthier switch.
Background Context
The rise of vaping as a smoking cessation tool accelerated in the 2010s, fueled by aggressive advertising and regulatory loopholes that classified e-cigarettes as tobacco products rather than cessation aids. Meanwhile, lung cancer rates among non-smokers have been rising globally, yet research has largely overlooked vapers as a potential high-risk group. The study’s scale—covering 4.5 million people—highlights how quickly vaping became mainstream without adequate long-term safety data.
What Happens Next
Public health agencies may need to reassess vaping as a recommended quitting strategy, especially for former smokers who switched under the assumption of reduced harm. Policymakers could face pressure to tighten regulations on e-cigarette flavorings and marketing, while researchers will likely prioritize studies on vaping’s carcinogenic pathways. For ex-smokers already vaping, this study may prompt reconsideration of their nicotine habits, even if quitting altogether remains the clearest path to risk reduction.
Bigger Picture
The findings underscore a recurring pattern in tobacco harm reduction: what appears safer in the short term may carry unforeseen long-term risks. As nicotine alternatives proliferate—from heated tobacco to synthetic nicotine products—the need for rigorous, independent research becomes critical. The study also raises broader questions about how society balances harm reduction with the potential for unintended consequences in public health strategies.
